CALGARY, ALBERTA–(EMWNews – July 23, 2008) – West Mountain Capital Corp. (TSX VENTURE:WMT) (“West Mountain”) is pleased to announce that Phase Separation Solutions Inc. (“PS2”), a wholly-owned subsidiary of West Mountain, has completed the acquisition of all of the issued and outstanding shares of 1095269 Ontario Limited, operating as Pharma Processing (“Pharma Processing”), based in Brampton, Ontario. Pharma Processing is a well known pharmaceutical waste management service provider that processes hazardous and non-hazardous pharmaceutical waste at its facility in Brampton, Ontario. Pharma Processing has been in operation since 1994. Please refer to West Mountain’s news release dated March 17, 2008 for additional information in respect of this acquisition.

About Phase Separation Solutions:

PS2 is an established Canadian company specializing in thermal treatment of a variety of hazardous and non-hazardous waste streams. It employs a unique indirectly heated, closed loop technology that allows it to extract even the most hazardous contaminants from soil, industrial sludge, and pharmaceutical waste and consumer waste streams converting much of it into reusable oil. PS2’s management team maintains expertise in hazardous waste management, brownfield remediation and pharmaceutical waste management with experience spanning North America and internationally throughout 14 countries.

This release may contain forward-looking statements. These statements are based on management’s current expectations and beliefs and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Forward-looking statements are not guarantees of future performance. Any forward-looking statements are made as of the date hereof and West Mountain Capital Corp. does not undertake any obligation, except as required under applicable law, to publicly update or revise such statements to reflect new information, subsequent or otherwise.

The TSX Venture Exchange has neither approved nor disapproved the contents of this press release.